ORIGINAL RESEARCH article
Front. Aging Neurosci.
Sec. Parkinson’s Disease and Aging-related Movement Disorders
Volume 17 - 2025 | doi: 10.3389/fnagi.2025.1612389
This article is part of the Research TopicMolecular mechanisms of neurodegenerationView all 15 articles
Nurr1 Deficiency Impairs Autophagy-Lysosomal Function Through GBA-Dependent Transcriptional Regulation in Parkinson's Disease Pathogenesis
Provisionally accepted- 1School of Public Health, Dalian Medical University, Dalian, Liaoning Province, China
- 2Liaoning Provincial Key Laboratory for Research on the Pathogenic Mechanisms of Neurological Diseases, First Affiliated Hospital, Dalian Medical University, Dalian, Liaoning Province, China
- 3The First Affiliated Hospital of USTC, University of Science and Technology of China, Department of Neuroelectrophysiology, Hefei, China
- 4Shandong First Medical University & Shandong Academy of Medical Sciences, Institute of Brain Science and Brain-inspired Research, Jinan, China
Select one of your emails
You have multiple emails registered with Frontiers:
Notify me on publication
Please enter your email address:
If you already have an account, please login
You don't have a Frontiers account ? You can register here
Introduction: The autophagy-lysosomal pathway (ALP) dysfunction and lysosomal impairment contribute to the pathogenesis of Parkinson's disease (PD). Nuclear receptor related protein 1 (Nurr1) maintains the differentiation and maturation of dopaminergic neurons, and mutants or polymorphism in Nurr1 is associated with familial and sporadic PD. Previous studies on Nurr1 have mainly focused on the development and maintenance of midbrain dopaminergic neurons, while the potential involvement of Nurr1 in ALP regulation remains uncharacterized. Methods: Stable Nurr1 knockdown cells and inducible Nurr1 knockout mice were generated. Transcriptome sequencing and analysis was utilized to confirm the altered pathways and differentially expression genes associated with ALP. Transmission Electron Microscopy observation was conducted to find the ultrastructure differences between the Nurr1 knockdown cells and the controls. The expression of LC3B and the colocalization of LC3B and Lamp1 were assessed. Lysosomal acidity in the Nurr1 knockdown cells and the controls was measured. The expression of lysosomal proteins (Lamp 1/2, CTSD and GBA) was determined in vitro and in vivo in the Nurr1-deficient models. Dualluciferase reporter gene assay was performed to detect the transcriptional activity of GBA. The key lysosomal proteins (Lamp 1/2 and CTSD) were assessed after GBA overexpression. Results: 22 terms and 45 differentially expression genes associated with ALP were identified by transcriptome analysis. Knockdown of Nurr1 induced intracellular aggregation of autophagosomes, increased endogenous expression of LC3B Ⅱ and elevated colocalization of exogenous GFP-LC3B with Lamp1. Lysosome dysfunction has been implicated with lysosomal alkalization and deprived level of lysosomal marker proteins with Nurr1 deficiency. GBA was transcriptionally downregulated by Nurr1 and Nurr1 deficiency-triggered lysosomal dysfunction were attenuated by GBA overexpression. Discussion: Our study provided the first experimental evidence that Nurr1 deficiency induced lysosomal dysfunction by alkalizing the lumen of lysosomes and downregulating the key lysosomal proteins (Lamp1, CTSD, Lamp2) expression in vivo and in vitro. Defective lysosomal function compromised lysosomal mediated autophagic vesicle clearance. Mechanistically, Nurr1 transcriptionally regulated GBA expression, which in turn governed lysosomal marker protein homeostasis through a GBA-dependent axis. This study illuminated the involvement of Nurr1 in the ALP and the interaction between PD-related genes in the pathogenesis of PD.
Keywords: Parkinson's disease, Nurr1, the autophagy-lysosomal pathway dysfunction, Lysosomal impairment, GBA
Received: 15 Apr 2025; Accepted: 05 Jun 2025.
Copyright: © 2025 Cheng, Yang, Tian, Ni, Jia, Le and Wang. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence:
Congcong Jia, Shandong First Medical University & Shandong Academy of Medical Sciences, Institute of Brain Science and Brain-inspired Research, Jinan, China
Weidong Le, Liaoning Provincial Key Laboratory for Research on the Pathogenic Mechanisms of Neurological Diseases, First Affiliated Hospital, Dalian Medical University, Dalian, 116011, Liaoning Province, China
Qingshan Wang, School of Public Health, Dalian Medical University, Dalian, 116044, Liaoning Province, China
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.